Neurology: Effect of Omega-3 Supplementation on Neuropathy in Type 1 Diabetes: A 12-Month Pilot Trial is organized by American Academy of Neurology (AAN) and will be held during Jun 13, 2017 - Jun 13, 2020.

The target audience for this medical event is Physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine. This CME Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credits.

Conference Objectives are :
Upon completion of the article by Lewis et al, the participant should be able to:
• Describe changes in corneal nerve fiber length after 12 months of supplementation observed in this study.
• Discuss what measures changed significantly for patients in this study without baseline diabetic sensorimotor polyneuropathy (DSP).
• Discuss what clinical assessments changed significantly between the baseline and 12-month measurements during this study.

Additional details will be posted as soon as they are available.

Intended Audience

Neurology, Nutrition, Pharmacy and Medicine

Activity Payment Details

Activity Fee : NA

Rate this CME (Min 1 - Max 5)

Fee and expenses:
CME credits:
Program contents:
Write Your Review

Reviews Given by Professionals

No Reviews available. Be the first to write a review.

Privacy Policy

Read eMedEvents Privacy Policy


American Academy of Neurology (AAN)

View Organizer Details


(800) 879-1960, (612) 928-6000